Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP196356.RA3O5Rm2WJMKvFwOPDbnMOPGK63OqgrQytSA9cC5_TYKE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP196356.RA3O5Rm2WJMKvFwOPDbnMOPGK63OqgrQytSA9cC5_TYKE130_assertion type Assertion NP196356.RA3O5Rm2WJMKvFwOPDbnMOPGK63OqgrQytSA9cC5_TYKE130_head.
- NP196356.RA3O5Rm2WJMKvFwOPDbnMOPGK63OqgrQytSA9cC5_TYKE130_assertion wasGeneratedBy ECO_0000203 NP196356.RA3O5Rm2WJMKvFwOPDbnMOPGK63OqgrQytSA9cC5_TYKE130_provenance.
- NP196356.RA3O5Rm2WJMKvFwOPDbnMOPGK63OqgrQytSA9cC5_TYKE130_assertion wasDerivedFrom lhgdn-20090331 NP196356.RA3O5Rm2WJMKvFwOPDbnMOPGK63OqgrQytSA9cC5_TYKE130_provenance.
- NP196356.RA3O5Rm2WJMKvFwOPDbnMOPGK63OqgrQytSA9cC5_TYKE130_assertion SIO_000772 17827395 NP196356.RA3O5Rm2WJMKvFwOPDbnMOPGK63OqgrQytSA9cC5_TYKE130_provenance.
- NP196356.RA3O5Rm2WJMKvFwOPDbnMOPGK63OqgrQytSA9cC5_TYKE130_assertion evidence source_evidence_literature NP196356.RA3O5Rm2WJMKvFwOPDbnMOPGK63OqgrQytSA9cC5_TYKE130_provenance.
- NP196356.RA3O5Rm2WJMKvFwOPDbnMOPGK63OqgrQytSA9cC5_TYKE130_assertion description "[activating FCGR2C-ORF genotype predisposes to idiopathic thrombocytopenic purpura by altering the balance of activating and inhibitory FcgammaR on immune cells ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP196356.RA3O5Rm2WJMKvFwOPDbnMOPGK63OqgrQytSA9cC5_TYKE130_provenance.